Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 86,182 $ 59,266 $ 239,047 $ 200,099
Cost of sales 68,176 54,271 198,219 183,592
Gross profit 18,006 4,995 40,828 16,507
Selling, general and administrative 6,948 6,275 21,941 21,088
Acquisition costs and other 201 656 201 803
Proxy contest costs and recoveries 0 207 168 3,105
Earn-out adjustments 160 (146) 1,430 (969)
Asset impairments 0 0 233 6,079
Goodwill impairment 0 10,748 0 10,748
Gain on lease modification 0 (171) 0 (171)
Operating income (loss) 10,697 (12,574) 16,855 (24,176)
Other expense (income)        
Interest expense 329 452 1,068 1,703
Loss on extinguishment of debt 0 0 223 0
Change in fair value of interest rate swaps 0 (16) (2) 65
Other, net (10) 59 152 (1,244)
Income (loss) before income taxes 10,378 (13,069) 15,414 (24,700)
Income tax provision (benefit) 2,179 (2,530) 3,235 (6,026)
Net income (loss) $ 8,199 $ (10,539) $ 12,179 $ (18,674)
Net income (loss) per common share:        
Basic (in dollars per share) $ 0.88 $ (1.16) $ 1.32 $ (2.06)
Diluted (in dollars per share) $ 0.87 $ (1.16) $ 1.30 $ (2.06)
Weighted average shares outstanding:        
Basic (in shares) 9,287 9,105 9,237 9,079
Dilutive effect from stock options and grants (in shares) 116 0 111 0
Diluted (in shares) 9,403 9,105 9,348 9,079